XML 25 R12.htm IDEA: XBRL DOCUMENT v3.22.2
Marketable Securities
6 Months Ended
Jun. 30, 2022
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities MARKETABLE SECURITIES

The following table represents the Company’s available-for-sale marketable securities:

 

 

 

As of June 30, 2022

 

 

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Fair
Value

 

U.S. government Treasury bills

 

$

405,458

 

 

$

 

 

$

(2,318

)

 

$

403,140

 

Total marketable securities

 

$

405,458

 

 

$

 

 

$

(2,318

)

 

$

403,140

 

 

 

 

As of December 31, 2021

 

 

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Fair
Value

 

U.S. government Treasury bills

 

$

241,369

 

 

$

 

 

$

(252

)

 

$

241,117

 

Total marketable securities

 

$

241,369

 

 

$

 

 

$

(252

)

 

$

241,117

 

 

The gross realized gains and losses related to the Company’s marketable securities were not material for the three and six months ended June 30, 2022 and 2021.

The following table presents the amortized cost and fair value of available-for-sale marketable securities by contractual maturity date:

 

 

 

As of

 

 

 

June 30, 2022

 

 

December 31, 2021

 

 

 

Amortized
Cost

 

 

Fair
Value

 

 

Amortized
Cost

 

 

Fair
Value

 

Due in one year or less

 

$

405,458

 

 

$

403,140

 

 

$

241,369

 

 

$

241,117

 

 

Investments in an unrealized loss position consisted of the following:

 

 

 

As of

 

 

 

June 30, 2022

 

 

December 31, 2021

 

 

 

Fair
Value

 

 

Gross
Unrealized
Losses

 

 

Fair
Value

 

 

Gross
Unrealized
Losses

 

U.S. government Treasury bills

 

$

403,140

 

 

$

(2,318

)

 

$

241,117

 

 

$

(252

)

Total investments in an unrealized loss position

 

$

403,140

 

 

$

(2,318

)

 

$

241,117

 

 

$

(252

)

 

As of June 30, 2022 and December 31, 2021, no investments were in a continuous unrealized loss position for more than 12 months. The Company does not intend to sell any of these investments and does not consider it more likely than not that the Company would be required to sell these investments before recovery of their amortized cost basis, which may be at maturity.